COVID-19 Clinical Guidelines–Special Populations

If we can assist your organization in the battle against COVID-19, whether or not you are a current member, please contact us today at clientservices@ecri.org.

2019-nCoV (coronavirus): recommendations and guidance for organ donor testing

Date: 2020 May 19
Developer: American Society of Transplantation (AST)

Guideline Focus
Organ donor testing

Patient Population
Patients receiving or donating organs during the COVID-19 pandemic

Major Interventions

  • Exposure, clinical, and laboratory screening of potential donors for COVID-19
  • Deceased donor screening and testing based on risk stratification
  • Living donor screening and testing
  • Timing considerations for elective living donor transplantation

Adapting care for older cancer patients during the COVID-19 pandemic: recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group

Date: 2020 Jul 16
Developer: International Society of Geriatric Oncology (SIOG)

Guideline Focus
Management of cancer in older patients during the COVID-19 pandemic

Patient Population
Older patients with cancer during the COVID-19 pandemic

Major Interventions

  • Infection control and minimizing infection risk
  • Goals of care and advance care planning
  • Geriatric assessment, including use of standardized tools and telehealth
  • Modifications to surgical, radiotherapy, and systemic treatment plans
  • Considerations for palliative care and survivorship

AGA Institute rapid recommendations for gastrointestinal procedures during the COVID-19 pandemic

Date: 2020 Aug
Developer: American Gastroenterological Association (AGA) Institute

Guideline Focus
Guidance for gastrointestinal procedures during the COVID-19 pandemic

Patient Population
Patients with COVID-19

Major Interventions

  • Gastrointestinal and liver manifestations of COVID-19
  • Risks to health care workers performing endoscopy
  • Use of necessary personal protective equipment (PPE) and personnel considerations during endoscopy
  • Use of negative pressure rooms for procedures
  • Endoscopic decontamination and reprocessing protocols
  • Triaging of gastrointestinal procedures

AGA Institute rapid review and recommendations on the role of pre-procedure SARS-CoV2 testing and endoscopy

Date: 2020 Jul 28
Developer: American Gastroenterological Association (AGA) Institute

Guideline Focus
Pre-endoscopy SARS-CoV2 testing

Patient Population
Patients requiring endoscopy during the COVID-19 pandemic

Major Interventions

  • Considerations for testing asymptomatic patients, including disease prevalence and test performance
  • Modifications to procedure scheduling for high prevalence areas
  • Guidance on use of serologic testing for patients and staff

American College of Rheumatology guidance for the management of adult patients with rheumatic disease during the COVID-19 pandemic: version 1

Date: 2020 Aug
Developer: American College of Rheumatology (ACRheum)

Guideline Focus
Management of rheumatic disease during the COVID-19 pandemic

Patient Population
Adult patients with rheumatic disease during the COVID-19 pandemic

Major Interventions

  • Patient counseling and shared decision-making
  • Management of chronic medications and initiation of new medications
  • Treatment considerations for patients with COVID-19 disease or exposure

ASCO special report: a guide to cancer care delivery during the COVID-19 pandemic

Date: 2020 May 19
Developer: American Society of Clinical Oncology (ASCO)

Guideline Focus
Cancer care delivery during the COVID-19 pandemic

Patient Population
Patients with cancer during the COVID-19 pandemic

Major Interventions

  • Patient triage, infection control, and COVID-19 testing
  • Staffing, inventory, and logistical considerations, including sanitation practices
  • Patient support and education
  • Use of telemedicine
  • Considerations for in-office medical oncology, radiation oncology, ancillary services, cancer screening, surgeries, and clinical trials

ASE statement on protection of patients and echocardiography service providers during the 2019 novel coronavirus outbreak

Date: 2020 Apr 1
Developer: American Society of Echocardiography (ASE)

Guideline Focus
Protection of patients and echocardiography service providers during the COVID-19 pandemic

Patient Population
Patients requiring echocardiography during the COVID-19 pandemic

Major Interventions

  • Indications for transthoracic and transesophageal echocardiogram
  • Location of study and screening of outpatients
  • Protocol for echocardiogram technique, and exclusion of learners and at-risk staff
  • Cleaning and disinfecting of equipment and exam rooms

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

Date: 2020 Jun
Developer: European Association for the Study of the Liver (EASL)/European Society of Clinical Microbiology and Infectious Diseases (ESCMID)

Guideline Focus
Care of patients with advanced liver disease and those after liver transplantation during the COVID-19 pandemic

Patient Population
Patients with pre-existing liver disease during the COVID-19 pandemic

Major Interventions

  • Outpatient management, including infection prevention, use of telemedicine, and deferral of routine imaging and diagnostic procedures
  • Inpatient care for patients with and without COVID-19
  • Pharmacological treatment options for patients with COVID-19
  • Ongoing treatment considerations for liver disease

Clinical insights for hepatology and liver transplant providers during the COVID-19 pandemic

Date: 2020 Apr 7
Developer: American Association for the Study of Liver Diseases (AASLD)

Guideline Focus
Hepatology and liver transplantation considerations during the COVID-19 pandemic

Patient Population
Patients with liver disease

Major Interventions

  • Management, and additional testing, for patients with COVID-19 and elevated liver enzymes
  • Diagnostic testing for patients with suspected COVID-19
  • Care of patients with liver disease during the pandemic, and guidance for patients awaiting liver transplantation, including ethical considerations
  • Care of post-liver transplant and immunosuppressed patients
  • Medication considerations, including drug-drug interactions
  • Protection of health care workers, utilization of telemedicine, and modifications to procedure scheduling, clinical research, and medical education

Consensus statement for patients with genetic heart disease and COVID-19

Date: 2020 Apr 7
Developer: Cardiac Society of Australia and New Zealand (CSANZ)

Guideline Focus
Management of patients with genetic heart disease and COVID-19

Patient Population
Patients with genetic heart disease and COVID-19

Major Interventions

  • Complication risk, exposure reduction, and importance of influenza vaccination
  • Continuation of current cardiac medications
  • Role of cardiologist in management of hospitalized patients
  • Considerations for specific conditions, including cardiomyopathy, Brugada syndrome, long QT syndrome, and catecholaminergic polymorphic ventricular tachycardia
  • Considerations for antipyretic treatment
  • Psychosocial support for families

Considerations for the management of home parenteral nutrition during the SARS-CoV-2 pandemic: a position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN

Date: 2020 Jul
Developer: European Society for Clinical Nutrition and Metabolism (ESPEN)

Guideline Focus
Management of home parenteral nutrition during the COVID-19 pandemic

Patient Population
Patients requiring home parenteral nutrition during the COVID-19 pandemic

Major Interventions

  • Role of multidisciplinary team and use of telemedicine
  • Modifications to role of home care workers
  • Triaging of laboratory, imaging, and procedural testing based on urgency
  • Hospital admission and discharge considerations
  • Presentation of, and evaluation for, COVID-19 in patients with chronic intestinal failure

COVID-19 and ENT Pediatric otolaryngology during the COVID-19 pandemic. Guidelines of the French Association of Pediatric Otorhinolaryngology (AFOP) and French Society of Otorhinolaryngology (SFORL)

Date: 2020 May
Developer: French Association of Pediatric Otorhinolaryngology (AFOP)/French Society of Otorhinolaryngology (SFORL)

Guideline Focus
Management of pediatric otolaryngology during the COVID-19 pandemic

Patient Population
Pediatric otolaryngology patients during the COVID-19 pandemic

Major Interventions

  • Disease incidence, severity, and prognosis for pediatric patients
  • Modifications to indications and precautions for nasal endoscopy, newborn hearing screen, saline nose wash, and tracheobronchial endoscopy
  • Modifications to surgical indications and techniques, including preoperative COVID-19 testing

COVID-19: guidance on palliative care from a European Respiratory Society International Task Force

Date: 2020 Sep 3
Developer: European Respiratory Society (ERS)

Guideline Focus
Palliative care during the COVID-19 pandemic

Patient Population
Patients with COVID-19 who are seriously ill

Major Interventions

  • Initial advance care planning and re-evaluation prior to discharge
  • Pharmacological and nonpharmacological palliative treatment options for distressing breathlessness
  • Considerations for communication techniques with patients and families
  • Role of health care professionals trained in providing palliative, spiritual, and psychosocial care
  • Guidance on support for family members of dying or deceased patients, and staff caring for patients with serious COVID-19

COVID-19 position statement: presentations and management of COVID-19 in older people in acute care. Version 1

Date: 2020 May 29
Developer: Scottish Intercollegiate Guidelines Network (SIGN)

Guideline Focus
Management of COVID-19 in hospitalized older patients

Patient Population
Older adult patients who have COVID-19

Major Interventions

  • Diagnostic considerations, including presenting symptoms, concurrent illnesses, laboratory testing, and frailty
  • Care planning, including palliation, family communication, and visitation
  • Age-specific management considerations
  • Considerations for patient movement, cohorting, and patients with delirium who wander
  • Planning for rehabilitation and safe discharge

COVID-19 rapid guideline: chronic kidney disease

Date: 2020 May 15
Developer: National Institute for Health and Care Excellence (NICE)

Guideline Focus
Management of chronic kidney disease during the COVID-19 pandemic

Patient Population
Adult patients with chronic kidney disease

Major Interventions

  • Patient communication and risk mitigation
  • Modifications to usual care, continuation of chronic medications, and monitoring considerations
  • Considerations for specialty referral, renal ultrasound, and hospital admission
  • Management of advanced kidney disease, including dialysis and transplantation
  • Role and management of health care workers with suspected COVID-19

COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD)

Date: 2020 Apr 9
Developer: National Institute for Health and Care Excellence (NICE)

Guideline Focus
Community-based care of patients with COPD during the COVID-19 pandemic

Patient Population
Patients with COPD during the COVID-19 pandemic

Major Interventions

  • Patient education, communication, and risk reduction
  • Factors associated with worse outcomes in COPD patients
  • Ongoing disease management and treatment considerations
  • Equipment use and cleaning
  • Provision of necessary prescriptions and modifications to usual care
  • Personal protective equipment (PPE) for health care team members and role of self-isolating health care team members

COVID-19 rapid guideline: cystic fibrosis

Date: 2020 Apr 9
Developer: National Institute for Health and Care Excellence (NICE)

Guideline Focus
Management of patients with cystic fibrosis during the COVID-19 pandemic

Patient Population
Patients with cystic fibrosis during the COVID-19 pandemic

Major Interventions

  • Patient education, communication, and risk reduction
  • Management considerations for patients with COVID-19
  • Provision of necessary prescriptions and modifications to usual care
  • Management and role of self-isolating health care team members

COVID-19 rapid guideline: delivery of radiotherapy

Date: 2020 Mar 28
Developer: National Institute for Health and Care Excellence (NICE)

Guideline Focus
Delivery of radiotherapy during the COVID-19 pandemic

Patient Population
Patients requiring radiotherapy

Major Interventions

  • Patient education, communication, and infection control
  • Care for patients suspected or known to have COVID-19
  • Assessment and management of patients with symptoms of COVID-19
  • Patient cohorting and scheduling for risk reduction
  • Guidance on isolation of staff and utilization of isolated staff to support care provision
  • Prioritization of treatments based on risk stratification and modification of care for risk reduction

COVID-19 rapid guideline: delivery of systemic anticancer treatments

Date: 2020 Mar 20
Developer: National Institute for Health and Care Excellence (NICE)

Guideline Focus
Provision of anticancer treatment during the COVID-19 pandemic

Patient Population
Patients with cancer

Major Interventions

  • Patient education, communication, and risk reduction
  • Infection prevention for patients and health care workers
  • Protocol for patients with symptoms of COVID-19
  • Guidance on isolation of staff and utilization of isolated staff to support care provision
  • Guidance on prioritizing patients for treatment
  • Role of treatment modifications and treatment break policy

COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response

Date: 2020 Apr 9
Developer: National Institute for Health and Care Excellence (NICE)

Guideline Focus
Treatment of dermatological conditions with drugs affecting the immune response during the COVID-19 pandemic

Patient Population
Adult and pediatric patients with dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic

Major Interventions

  • Patient education, communication, and risk reduction
  • Provision of necessary prescriptions and modifications to usual care
  • Initiation of new treatments for patients with and without COVID-19
  • Management of topical and systemic medications for patients with COVID-19
  • Personal Protective Equipment (PPE) for health care team members and role of self-isolating health care team members

COVID-19 rapid guideline: dialysis service delivery

Date: 2020 Mar 20
Developer: National Institute for Health and Care Excellence (NICE)

Guideline Focus
Dialysis delivery during the COVID-19 pandemic

Patient Population
Patients on dialysis

Major Interventions

  • Patient education, communication, and risk reduction
  • Infection prevention for patients and health care workers
  • Patient triage, screening, cohorting, and transport
  • Operational planning and staffing considerations
  • Protocols for home dialysis and dialysis units

COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response

Date: 2020 Apr 23
Developer: National Institute for Health and Care Excellence (NICE)

Guideline Focus
Management of patients with gastrointestinal (GI) and liver conditions taking drugs affecting the immune response during COVID-19 pandemic

Patient Population
Children and adults with GI and liver conditions taking drugs affecting the immune response during COVID-19 pandemic

Major Interventions

  • Communicating with patients and infection prevention
  • Management of patients with and without COVID-19, including initiation and maintenance of chronic medications
  • Modifications to usual care, including appointments, procedures, and provision of medications
  • Role and management of health care workers with suspected COVID-19

COVID-19 rapid guideline: haematopoietic stem cell transplantation

Date: 2020 Apr 1
Developer: National Institute for Health and Care Excellence (NICE)

Guideline Focus
Management of hematopoietic stem cell transplantation during the COVID-19 pandemic

Patient Population
Adult and pediatric patients requiring hematopoietic stem cell transplantation

Major Interventions

  • Patient education, communication, and infection control
  • Assessment and management of patients with symptoms of COVID-19
  • Pre-transplant management for recipients and donors with and without COVID-19
  • Post-transplant care for recipients
  • Guidance on isolation of staff and utilization of isolated staff to support care provision
  • Prioritization of treatment based on risk stratification and modification of care for risk reduction

COVID-19 rapid guideline: interstitial lung disease

Date: 2020 May 15
Developer: National Institute for Health and Care Excellence (NICE)

Guideline Focus
Management of interstitial lung disease during the COVID-19 pandemic

Patient Population
Adult patients with interstitial lung disease

Major Interventions

  • Patient communication and risk mitigation
  • Assessment of symptoms for COVID-19 and interstitial lung disease
  • Modifications to care, including new referrals, laboratory testing, procedures, and medication provision
  • Considerations for starting and continuing immunosuppressive therapy
  • Management of oxygen needs, pulmonary rehabilitation, and lung transplantation referral
  • Diagnostic and management considerations, including modifications to chronic medications

COVID 19 rapid guideline: renal transplantation

Date: 2020 Jun 19
Developer: National Institute for Health and Care Excellence (NICE)

Guideline Focus
Renal transplantation during the COVID-19 pandemic

Patient Population
Adult and pediatric patients who need or have had a kidney transplant or are donating a kidney during the COVID-19 pandemic

Major Interventions

  • Administrative and organizational considerations for regional renal networks and transplant programs
  • Infection control measures and precautions for transplant recipients and donors
  • Management of transplant wait list status for patients with COVID-19
  • Modifications to management at the time of transplant
  • Communicating with patients and minimizing in person interactions
  • Role of self-isolating health care team members

COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders

Date: 2020 Apr 3
Developer: National Institute for Health and Care Excellence (NICE)

Guideline Focus
Management of patients with rheumatological autoimmune, inflammatory, and metabolic bone disorders during the COVID-19 pandemic

Patient Population
Adult and pediatric patients with rheumatological autoimmune, inflammatory, and metabolic bone disorders with and without COVID-19

Major Interventions

  • Communicating with patients and infection prevention
  • Minimizing potential exposure in patients not known to have COVID-19
  • Infection control and medication management in patients with known or suspected COVID-19
  • Ongoing treatment considerations including NSAIDS, corticosteroids, biological treatments, immunoglobulins, bisphosphonates, denosumab, prostaglandins, and drug monitoring
  • Modifying practices for standard care including new referrals and inpatient wards
  • Role and management of self-isolating healthcare team members

COVID-19 rapid guideline: severe asthma

Date: 2020 Apr 3
Developer: National Institute for Health and Care Excellence (NICE)

Guideline Focus
Management of patients with severe asthma during the COVID-19 pandemic

Patient Population
Adult and pediatric patients with severe asthma

Major Interventions

  • Communicating with patients and infection prevention
  • Considerations for bronchoscopy and pulmonary function tests
  • Management of biological treatments and corticosteroids
  • Care of respiratory equipment
  • Modifications to usual care

CSANZ position statement on COVID-19 from the Paediatric and Congenital Council

Date: 2020 May 25
Developer: Cardiac Society of Australia and New Zealand (CSANZ)

Guideline Focus
Cardiac considerations during COVID-19 pandemic

Patient Population
Pediatric patients with heart disease and adult patients with congenital heart disease (CHD) during COVID-19 pandemic

Major Interventions

  • Multispecialty management and surveillance of multi-system inflammatory syndrome
  • Continuation of angiotensin-converting enzyme (ACE) inhibitors, prophylactic penicillin, and influenza vaccination
  • Modifications to care provision for patients with CHD
  • Use of personal protective equipment (PPE) and infection control measures
  • Communication with patients and families

Guidance for cardiac electrophysiology during the coronavirus (COVID-19) pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association

Date: 2020 Sep
Developer: Heart Rhythm Society (HRS)/American College of Cardiology (ACC)/American Heart Association (AHA)

Guideline Focus
Cardiac electrophysiology during the COVID-19 pandemic

Patient Population
Patients with cardiac arrhythmias with and without COVID-19

Major Interventions

  • Measures to minimize exposure risk
  • Guidance on urgent, semi-urgent, and elective cardiac procedure classification
  • Impact of COVID-19 on cardiac arrhythmias
  • Triaging of invasive and non-invasive procedures
  • Modifications to office visit schedule, use of telemedicine, and remote device monitoring
  • Use of personal protective equipment (PPE) by health care workers and resource conservation
  • Management of cardiopulmonary resuscitation (CPR), advanced cardiovascular life support (ACLS), and arrhythmia for COVID-19 patients

Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network

Date: 2020 Jun
Developer: French Rare Health Care for Neuromuscular Diseases Network (FILNEMUS)

Guideline Focus
Management of neuromuscular disease during the COVID-19 pandemic

Patient Population
Patients with neuromuscular disease during the COVID-19 pandemic

Major Interventions

  • Management of communication, appointments, and alterations to the availability of physiotherapy
  • Modifications to treatments usually administered during hospitalization
  • Considerations for immunosuppressive, immunomodulating, and cardiac treatments
  • Conduction of clinical trials
  • Considerations for routine treatment and emergency management in the context of COVID-19

Guidelines for COVID-19 management in hematopoietic cell transplant and cellular therapy patients

Date: 2020 Jul 28
Developer: American Society for Transplantation and Cellular Therapy (ASTCT)

Guideline Focus
Diagnosis and management of COVID-19 in hematopoietic cell transplant (HCT) and cellular therapy patients

Patient Population
Adult and pediatric HCT and cellular therapy patients with COVID-19

Major Interventions

  • Diagnostic considerations for symptomatic and asymptomatic patients, and guidance on use of serology
  • Evaluation of HCT candidates, cellular therapy candidates, and donor candidates
  • Infection prevention measures for staff, patients, and physical environment
  • Treatment considerations for patients with COVID-19, including general principles and pharmacological therapy
  • Survivorship considerations

Mechanical thrombectomy in the era of the COVID-19 pandemic: emergency preparedness for neuroscience teams: a guidance statement from the Society of Vascular and Interventional Neurology

Date: 2020 Jun
Developer: Society of Vascular and Interventional Neurology (SVIN)

Guideline Focus
Mechanical thrombectomy during COVID-19 pandemic

Patient Population
Patients with acute ischemic stroke during COVID-19 pandemic

Major Interventions

  • Prehospital screening and triage
  • Airway and thrombectomy room preparation
  • Intraprocedure risk reduction modifications
  • Postthrombectomy care and psychosocial interventions
  • Transfer to postacute care and testing considerations

Management and care of tracheostomised patients with prolonged disorders of consciousness during the COVID-19 crisis

Date: 2020 Apr
Developer: Royal College of Physicians (RCP)

Guideline Focus
Management and care of tracheostomised patients with prolonged disorders of consciousness during the COVID-19 pandemic

Patient Population
Patients with tracheostomies and prolonged disorders of consciousness in inpatient and outpatient settings during the COVID-19 pandemic

Major Interventions

  • Principles and planning for treatment escalation
  • Infection risk reduction and use of personal protective equipment (PPE)
  • Considerations for resource-limited circumstances

Management of acute myocardial infarction during the COVID-19 pandemic: a consensus statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP)

Date: 2020 Aug
Developer: Society for Cardiovascular Angiography and Interventions (SCAI)/American College of Cardiology (ACC)/American College of Emergency Physicians (ACEP)

Guideline Focus
Management of acute myocardial infarction (AMI) during the COVID-19 pandemic

Patient Population
Patients with AMI during the COVID-19 pandemic

Major Interventions

  • Management of specific clinical scenarios, including possible and definite ST-elevation myocardial infarction (STEMI), presentation to primary percutaneous coronary intervention (PCI) centers and referral centers, non-STEMI, out-of-hospital cardiac arrest, and futile prognosis
  • Use of personal protective equipment (PPE) by staff in the cardiac catheterization lab, by prehospital care providers, and by patients
  • Role of ED evaluation for all STEMI patients prior to cardiac catheterization lab activation
  • Modifications to intubation protocol and patient disposition
  • Considerations for regional systems of STEMI care
  • Algorithms for patient management during the COVID-19 pandemic

Management of lung nodules and lung cancer screening during the COVID-19 pandemic: CHEST Expert Panel report

Date: 2020 Jul
Developer: American College of Chest Physicians (CHEST)

Guideline Focus
Lung nodule evaluation and lung cancer screening during the COVID-19 pandemic

Patient Population
Patients with lung nodules or requiring lung cancer screening during the COVID-19 pandemic

Major Interventions

  • Considerations for baseline and annual screenings
  • Surveillance of a previously detected lung nodule
  • Evaluation of intermediate- and high-risk lung nodules
  • Management of clinical stage I non-small cell lung cancer (NSCLC)

Management of referral, triage, waitlist and reassessment of cardiac patients during the COVID-19 pandemic

Date: 2020 Apr 7
Developer: Canadian Cardiovascular Society

Guideline Focus
Management of cardiac patients during the COVID-19 pandemic

Patient Population
Patients with cardiac conditions during the COVID-19 pandemic

Major Interventions

  • Modifications to clinical visits, including utilization of telemedicine
  • Triaging of urgent and non-urgent diagnostic testing
  • Modifications to scheduling of elective and urgent therapeutic procedures
  • Planning for resumption of services

Managing cancer patients during the COVID-19 pandemic: an ESMO interdisciplinary expert consensus

Date: 2020 Jul 29
Developer: European Society for Medical Oncology (ESMO)

Guideline Focus
Managing cancer patients during the COVID-19 pandemic

Patient Population
Patients with cancer during the COVID-19 pandemic

Major Interventions

  • Modifications to routine care
  • Preventive measures for patients and staff
  • Routine preadmission testing, choice of test, and interpretation
  • Expanded use of granulocyte-colony stimulating factors (G-CSF) and considerations for thromboembolic prevention and management
  • Treatment modifications for patients with COVID-19
  • Prioritization of adjuvant therapies based on cancer type
  • Considerations for severe COVID-19 infection
  • Considerations for clinical trial participation

Patient management and clinical recommendations during the coronavirus (COVID-19) pandemic

Date: 2020 Mar 17 (Update 8: 2020 Sep 8)
Developer: American Society for Reproductive Medicine (ASRM)

Guideline Focus
Management of patients with infertility during the COVID-19 pandemic

Patient Population
Adult patients undergoing treatment for infertility during the COVID-19 pandemic

Major Interventions

  • Impact of COVID-19 on pregnancy
  • Risk mitigation, social distancing, patient travel, and considerations for health care workers undergoing fertility treatment
  • Management of urgent and “in-cycle” patients
  • Modifications to appointment, surgical, and procedure scheduling, including use of telehealth
  • Laboratory considerations, including staffing and specimen handling
  • Emotional and psychological support of patients and staff, including considerations for presence of partners
  • Preparation and protocols for resumption of care, including formal risk assessment, personal protective equipment (PPE) use, considerations for third-party reproduction, policies, and procedures
  • Addressing misinformation with patients and encouraging early flu vaccination

Position statement on the management of cardiac electrophysiology and cardiac implantable electronic devices in Australia during the COVID-19 pandemic: a living document from the Heart Rhythm Council COVID-19 Pandemic working group, Cardiac Society of Australia and New Zealand. Version 3

Date: 2020 Jun 11
Developer: Cardiac Society of Australia and New Zealand (CSANZ)

Guideline Focus
Management of cardiac electrophysiology and cardiac implantable electronic devices during the COVID-19 pandemic

Patient Population
Adult and pediatric patients with cardiac arrhythmias during the COVID-19 pandemic

Major Interventions

  • Modifications to care provision based on capacity level, including screening, tele-conferencing, use of clinical based teams, and rescheduling of non-urgent appointments and procedures
  • Monitoring and follow up of patients with implantable devices, including remote monitoring
  • Guidance on use of ambulatory monitoring, including Holter monitors and exercise stress tests
  • Delineation of procedures by urgency and related scheduling modification considerations
  • Arrhythmic implications of COVID-19
  • Considerations for children and adults with congenital heart disease

Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: an ESTRO-ASTRO consensus statement

Date: 2020 May
Developer: European Society for Radiotherapy and Oncology (ESTRO) / American Society for Radiation Oncology (ASTRO)

Guideline Focus
Management of lung cancer radiotherapy during the COVID-19 pandemic

Patient Population
Patients requiring lung cancer radiotherapy during the COVID-19 pandemic

Major Interventions

  • Treatment modifications for risk mitigation based on clinical scenario
  • Treatment modifications in the setting of reduced radiotherapy resources
  • Guidance on treatment postponement and fractionation adjustments based on clinical scenario
  • Treatment modifications for patients with COVID-19
  • Criteria for patient triaging

Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement

Date: 2020 Jul 15
Developer: European Society for Radiotherapy and Oncology (ESTRO)/American Society for Radiation Oncology (ASTRO)

Guideline Focus
Risk-adapted head and neck cancer radiotherapy during COVID-19 pandemic

Patient Population
Patients with head and neck cancer requiring radiotherapy during COVID-19 pandemic

Major Interventions

  • Prioritization of treatment based on clinical scenario and resource availability
  • Treatment modifications for patients with intercurrent COVID-19 infection
  • Guidance on dose-fractionation, concomitant chemotherapy, and induction chemotherapy
  • Considerations for medical treatment modifications if operating rooms are closed
  • Adjustments to outpatient clinic appointments and supportive care

Recommendations by the Sociedad Española de Patología Digestiva (SEPD) and Asociación Española de Gastroenterología (AEG), both in general and on the operation of gastrointestinal endoscopy and gastroenterology units, concerning the current SARSCoV-2 pandemic (March, 18)

Date: 2020 Apr
Developer: Sociedad Espanola De Patologia Digestiva (SEPD)/Asociacion Espanola De Gastroenterologia (AEG)

Guideline Focus
Guidance for endoscopy during the COVID-19 pandemic

Patient Population
Patients requiring endoscopy during the COVID-19 pandemic

Major Interventions

  • Personnel considerations, including team formation and scheduling
  • Delay of endoscopic procedures when possible for patients with and without COVID-19
  • Stratification of infection risk based on procedure type
  • Preparation of patients, including screening, companion requirements, and hand washing
  • Personal protective equipment (PPE) use for procedures stratified by exposure risk level
  • Checklist for procedure preparedness
  • Processing of endoscopes and cleaning of procedure rooms

Rural and remote cardiology during the COVID-19 pandemic: CSANZ consensus statement

Date: 2020 Apr 11
Developer: Cardiac Society of Australia and New Zealand (CSANZ)

Guideline Focus
Rural and remote cardiology during COVID-19 pandemic

Patient Population
Patients requiring cardiac care during COVID-19 pandemic

Major Interventions

  • Use of telehealth and remote access to team meetings
  • Access to care, stocking of supplies, and transfer of unstable patients
  • Modifications to, and maintenance of, outpatient cardiac care
  • Provision of personal protective equipment (PPE) for health care workers and onsite COVID PCR testing
  • Considerations surrounding redeployment of specialist cardiac nursing staff
  • Need for a modified regional and rural plan to support access to pacing and defibrillator services
  • Continuation of referrals for urgent cardiothoracic surgery

Thoracic anesthesia of patients with suspected or confirmed 2019 novel coronavirus infection: preliminary recommendations for airway management by the EACTA Thoracic Subspecialty Committee

Date: 2020 Sep
Developer: European Association of Cardiothoracic Anaesthesiology (EACTA)

Guideline Focus
Management of thoracic anesthesia for patients with COVID-19

Patient Population
Patients with suspected or confirmed COVID-19 requiring thoracic anesthesia

Major Interventions

  • Planning and execution of airway securement, including use of personal protective equipment (PPE)
  • Intraoperative and postoperative considerations, including procedure and equipment modifications

The use of bronchoscopy during the COVID-19 pandemic: CHEST/AABIP guideline and Expert Panel report

Date: 2020 Sep
Developer: American College of Chest Physicians (CHEST)/American Association for Bronchology and Interventional Pulmonology (AABIP)

Guideline Focus
Role of bronchoscopy during the COVID-19 pandemic

Patient Population
Patients requiring bronchoscopy during the COVID-19 pandemic

Major Interventions

  • Use of appropriate personal protective equipment (PPE) in procedure and recovery rooms
  • Use of nasopharyngeal testing for patients with suspected COVID-19 and indications for proceeding with bronchoscopy
  • Pre-bronchoscopy testing for COVID-19 in asymptomatic patients
  • Considerations for patients with known or suspected lung cancer
  • Timing of routine bronchoscopy following COVID-19 infection

Return to the ECRI COVID-19 Resource Center